VERU INC. Net Income (Loss) Available to Common Stockholders, Basic
VERU INC. (VERU) reported Net Income (Loss) Available to Common Stockholders, Basic of -$23.94 million for the 12-month period ending 2018-09-30, per its 10-K filed 2018-12-13.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2018-12-13
- VERU INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-09-30 was -$4.67M.
- VERU INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-06-30 was -$789.89K.
- VERU INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-03-31 was -$1.78M.
- VERU INC. net income (loss) available to common stockholders, basic for the quarter ending 2016-12-31 was -$1.37M.
- VERU INC. net income (loss) available to common stockholders, basic for fiscal 2018 was -$23.94M.
- VERU INC. net income (loss) available to common stockholders, basic for fiscal 2017 was -$8.60M, a 2595.56% decline from fiscal 2016.
- VERU INC. net income (loss) available to common stockholders, basic for fiscal 2016 was $344.73K, a 92.07% decline from fiscal 2015.
- VERU INC. net income (loss) available to common stockholders, basic for fiscal 2015 was $4.35M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2018-09-30 | -$23.94M 10-K · filed 2018-12-13 | |||
| 2017-09-30 | -$4.67M 10-K · filed 2018-01-02 | -$5.46M derived: sum of 2 quarters · filed 2018-01-02 | -$7.24M derived: sum of 3 quarters · filed 2018-01-02 | -$8.60M 10-K · filed 2018-12-13 |
| 2017-06-30 | -$789.89K 10-K · filed 2018-01-02 | -$2.57M derived: sum of 2 quarters · filed 2018-01-02 | -$3.93M derived: sum of 3 quarters · filed 2018-01-02 | |
| 2017-03-31 | -$1.78M 10-K · filed 2018-01-02 | -$3.14M derived: sum of 2 quarters · filed 2018-01-02 | ||
| 2016-12-31 | -$1.37M 10-K · filed 2018-01-02 | |||
| 2016-09-30 | $344.73K 10-K · filed 2018-01-02 | |||
| 2015-09-30 | $4.35M 10-K · filed 2018-01-02 | |||
| 2011-09-30 | $5.40M 10-K · filed 2011-12-02 | |||
| 2010-09-30 | $6.74M 10-K · filed 2011-12-02 | |||
| 2009-09-30 | $6.46M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |